Fitzsimons Innovation Community
Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

Blog
LIGHT LABS Celebrates 10 Years of Success at Fitzsimons Innovation Community
April 23, 2024
Blog
Fitzsimons Innovation Community Celebrates Women Leaders
March 26, 2024
Blog
Fitzsimons Innovation Community Partners with the Colorado Hub for Health Impact Campaign
February 27, 2024
Pharmaceutical Executive Podcast
News | Oct 28, 2021

Pharmaceutical Executive Podcast

Amie Krause, Senior Vice President and Chief People Officer, and Kristin Yarema, Chief Commercial Officer, of Atara Biotherapeutics, discuss women in leadership positions in pharma and the effects of a gender diverse company.

CU Innovations Wins $50,000 Grant to Support Diversity in Entrepreneurship and Innovation
News | Oct 26, 2021

CU Innovations Wins $50,000 Grant to Support Diversity in Entrepreneurship and Innovation

Many studies have shown that companies with diverse leadership and innovation teams are the most successful and profitable.

University of Colorado Received $1.45 Billion in Research Funding in 2021
News | Oct 25, 2021

University of Colorado Received $1.45 Billion in Research Funding in 2021

Faculty within the University of Colorado system received a total of $1.45 billion in sponsored research funding and research gifts this year…

Even with Constrained Lab Space, Denver Ranks as a Top Bioscience Market
News | Oct 18, 2021

Even with Constrained Lab Space, Denver Ranks as a Top Bioscience Market

The Denver-Boulder market ranks among the top 10 bioscience markets in the U.S and Canada, according to a new report…

Gates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta
News | Oct 12, 2021

Gates Biomanufacturing Facility Announces Strategic Manufacturing Agreement with Cell Therapy Pioneer, Nkarta

The Gates Biomanufacturing Facility announced a continued strategic agreement with Nkarta, Inc. to manufacture clinical supply of therapeutic Natural Killer (NK) cells.

© 2024

 Fitzsimons Innovation Community